The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations
about
Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical PictureHantavirus protein interactions regulate cellular functions and signaling responses.High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica.Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infectionHantavirus infections for the clinician: from case presentation to diagnosis and treatment.Thrombocytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infectionsAcute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica.Severe thrombocytopenia in hantavirus-induced nephropathia epidemica.Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, GermanyIncreased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients.Puumala Hantavirus-Induced Hemorrhagic Fever with Renal Syndrome Must Be Considered across the Borders of Nephrology to Avoid Unnecessary Diagnostic Procedures.Thrombocytopenia associates with the severity of inflammation and variables reflecting capillary leakage in Puumala Hantavirus infection, an analysis of 546 Finnish patients.Immune response in Dobrava-Belgrade virus infections.Elevated thrombopoietin and platelet indices confirm active thrombopoiesis but fail to predict clinical severity of puumala hantavirus infection.Immunogenetic factors affecting susceptibility of humans and rodents to hantaviruses and the clinical course of hantaviral disease in humans.Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome.Cytokine expression during early and late phase of acute Puumala hantavirus infection.Plasma cell-free DNA levels are elevated in acute Puumala hantavirus infection.The degree of leukocytosis and urine GATA-3 mRNA levels are risk factors for severe acute kidney injury in Puumala virus nephropathia epidemicaPlasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infectionInvolvement of the Akt/NF-κB pathways in the HTNV-mediated increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs.Association of low serum TGF-β level in hantavirus infected patients with severe diseaseUrinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) and proteinuria predict severity of acute kidney injury in Puumala virus infection.RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge.Elevated cerebrospinal fluid neopterin concentration is associated with disease severity in acute Puumala hantavirus infection.Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle.Rodent-borne hemorrhagic fevers: under-recognized, widely spread and preventable - epidemiology, diagnostics and treatment.Kidney disease in Puumala hantavirus infection.Serum levels of interleukin-6 are linked to the severity of the disease caused by Andes Virus.Inflammatory cytokines kinetics define the severity and phase of nephropathia epidemica.Upregulation of IFN-γ and IL-12 is associated with a milder form of hantavirus hemorrhagic fever with renal syndrome.Elevated serum concentrations of inflammatory cytokines and chemokines in patients with haemorrhagic fever with renal syndrome.Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission.Proteinuria and the Clinical Course of Dobrava-Belgrade Hantavirus Infection.
P2860
Q26766338-5858A6F5-11EA-4B73-96E1-5F2635562350Q30226803-A722C874-FDDC-47A8-B61A-8AFEA80099E9Q33397083-98844A03-42D6-44B3-91E2-E44F3C79ECD9Q33398521-55D3393E-0353-445E-9B39-E3C7D9B492FCQ33401056-EC49F406-D9F0-453E-8417-386C1053AC75Q33405193-04F89A86-F9AC-43AD-AF84-43BC0067B92BQ33418184-80134876-339A-4AF0-B36C-C3A45957E3B0Q33418608-D1FB4735-A806-4505-9841-464CFC27CE5AQ33419454-20CCF40D-8510-4C63-A928-4B5345E0E60BQ33421116-038D6657-628D-4107-8FE7-754645C21261Q33428281-1B71CBD4-7FC9-48BD-AA18-2C0A1A3A0B79Q33433061-0EA4BC6D-E64D-4871-AF43-3D40963FC09CQ33435322-0CF74BA7-8DDD-429F-A0A8-D65A37522EC0Q33437960-56D557E5-69E0-4099-8628-9F6D17EA75F7Q33677586-9CF99840-0547-4E8B-9B8A-5F6FDB8A09C7Q33909193-72B571A3-303A-4364-B9CB-8A96E0323A6BQ34074807-115C2446-89A0-4E3D-AB38-49AA2715B131Q34162853-3AA7C48C-605C-4E8F-AAFF-8370C121101BQ34241845-1FFD359A-547C-4D36-B5B4-031112DD16A4Q34976988-154F1343-8813-463B-A133-37EB94D15920Q35142776-62994E9E-76AD-4D10-AEC0-4D4186CB09D7Q35440371-D0ECD25B-E936-47A2-815A-E2FEED8DB20BQ35822229-49C4087F-C9D2-4363-9577-290BA4530757Q36759999-866A564F-41CE-42B6-A733-F3E77C6EF8CBQ37105392-6EA562E1-A53C-4765-874D-2BDDEF31E222Q37665363-4E885905-5F8F-407E-9AD5-03DA4B2AD609Q38016471-95D966A1-C0BD-4038-AF15-5E877C248DAFQ38775159-E8A4D01A-301A-46E9-83EE-DA9C59462DDAQ40122618-BF9563F0-B9CA-4D09-B14B-78EBD6A1FADFQ40187061-FEDD0B99-D2D7-44DE-9A5D-86D173B07FABQ40203300-D589927A-8CEB-454D-A324-2BB1BDD3EF93Q40286190-A1E678C4-2874-4D31-81EC-2477C3C9160AQ55258016-645E1FC0-000D-488E-97F9-156A0C4AB2D9Q55263689-9A4B14B9-804F-418A-ACE7-C05EA2BEF021
P2860
The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The severity of Puumala hantav ...... eactive protein determinations
@ast
The severity of Puumala hantav ...... eactive protein determinations
@en
The severity of Puumala hantav ...... active protein determinations.
@nl
type
label
The severity of Puumala hantav ...... eactive protein determinations
@ast
The severity of Puumala hantav ...... eactive protein determinations
@en
The severity of Puumala hantav ...... active protein determinations.
@nl
prefLabel
The severity of Puumala hantav ...... eactive protein determinations
@ast
The severity of Puumala hantav ...... eactive protein determinations
@en
The severity of Puumala hantav ...... active protein determinations.
@nl
P2093
P2860
P356
P1476
The severity of Puumala hantav ...... eactive protein determinations
@en
P2093
Antti S Paakkala
Heini Sa Huhtala
Ilkka H Pörsti
Ilpo O Ala-Houhala
Jaana T Syrjänen
Jukka T Mustonen
Mikko Hurme
Tuula K Outinen
P2860
P2888
P356
10.1186/1471-2334-10-132
P50
P577
2010-05-25T00:00:00Z
P5875
P6179
1043311246